India: Healthcare focussed PE fund Quadria to pick 20% in Concord Biotech

India: Healthcare focussed PE fund Quadria to pick 20% in Concord Biotech

A file photo of Rakesh Jhunjhunwala, who holds about 30% in Concord, is said to remain the single largest shareholder even after the transaction. Photo: Mint

Actis CapitalAdventAsia healthcareCapital International Private Equity FundsCARE hospotalsChrysCapitalconcord biotechMankind PharmaMatrix LabMylan NVo3 Capital Global Advisory Pvt. LtdPEquadriaRakesh JhunjhunwalaRanbaxy Laboratories LtdSOHOTemasek

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.